Cancer Family
Notochordal Tumor
CI-CAN-00000294Explore in graph →
Non-malignant15 active trials1 evidence items
- NCIt
- C7063
Loading cancer entity…
Cancer Family
CI-CAN-00000294Explore in graph →
Clinical trials
58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02601950 | A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma | completed | Phase 2 | 267 | Epizyme, Inc.INDUSTRY | 9 | Jun 22, 2025 | clinicaltrials |
| NCT03190174 | Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers | completed | Phase 1 / Phase 2 | 34 | Sarcoma Oncology Research Center, LLCOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT03083678 |
| Afatinib in Locally Advanced and Metastatic Chordoma |
| completed |
| Phase 2 |
| 43 |
| Leiden University Medical CenterOTHER |
| 3 |
| Feb 13, 2025 |
| clinicaltrials |
| NCT02383498 | QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma | completed | Phase 2 | 24 | NantCell, Inc.INDUSTRY | 1 | May 20, 2024 | clinicaltrials |
| NCT03623854 | Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma | completed | Phase 2 | 10 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03595228 | BN Brachyury and Radiation in Chordoma | completed | Phase 2 | 29 | Bavarian NordicINDUSTRY | 1 | Apr 14, 2023 | clinicaltrials |
| NCT03110744 | CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma(NCT-PMO-1601) | completed | Phase 2 | 43 | University Hospital HeidelbergOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT00464620 | Trial of Dasatinib in Advanced Sarcomas | completed | Phase 2 | 366 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Nov 23, 2018 | clinicaltrials |
| NCT00592748 | Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine | completed | Phase 1 / Phase 2 | 381 | Massachusetts General HospitalOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT00150072 | Efficacy and Safety of Imatinib in Chordoma | completed | Phase 2 | 55 | Novartis PharmaceuticalsINDUSTRY | 2 | Feb 23, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Jun 22, 2025source: clinicaltrials